Preferred Label : Interstitial lung disease 2;
Symbol : ILD2;
CISMeF acronym : IPF; UIP;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Idiopathic pulmonary fibrosis, familial; Fibrosing alveolitis, cryptogenic; Fibrocystic pulmonary dysplasia; Interstitial pneumonitis, usual; UIP; IPF; Pulmonary fibrosis, idiopathic;
Included titles and symbols : Hamman-rich disease;
Description : Idiopathic pulmonary fibrosis is one of a family of idiopathic pneumonias sharing
clinical features of shortness of breath, radiographically evident diffuse pulmonary
infiltrates, and varying degrees in inflammation, fibrosis, or both on lung biopsy.
In some cases, the disorder can be rapidly progressive and characterized by sequential
acute lung injury with subsequent scarring and end-stage lung disease. Although older
studies included several forms of interstitial pneumonia under the term 'idiopathic
pulmonary fibrosis,' the clinical label of 'pulmonary pulmonary fibrosis' should be
reserved for patients with a specific form of fibrosing interstitial pneumonia referred
to as usual interstitial pneumonia (Gross and Hunninghake, 2001). It is estimated
that 0.5 to 2.2% of cases of idiopathic pulmonary fibrosis are familial (Marshall
et al., 2000). Pulmonary fibrosis can also be a feature in patients with mutations
in the TERT (187270) or the TERC (602322) gene; see PFBMFT1 (614742) and;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the pulmonary-associated surfactant protein A2 gene (SFTPA2,
178642.0001);
Neoplasia : Alveolar cell carcinoma (some); Bronchogenic carcinoma (some); Adenocarcinoma of lung (some);
Prefixed ID : #178500;
Origin ID : 178500;
UMLS CUI : C5561926;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT